INDIANA – The U.S. Food and Drug Administration (FDA) is announcing the virtual public workshop with the National Institutes of Health’s (NIH)’s National Eye Institute (NEI), “Patient-Reported Outcomes and Vision-Related Quality of Life Questionnaires.”
- Date: Friday, September 29, 2023, from 10 a.m. to 4 p.m. ET
- Location: The public workshop is virtual.
- Registration: Required to receive the virtual workshop link.
The virtual public workshop will:
- Highlight the importance of patients’ perspectives, patient-reported outcomes, and questionnaires to measure visual function and vision-related quality of life in vision research and clinical care.
- Help to identify future steps in developing patient-reported outcomes and visual function and vision-related quality of life for a variety of ocular conditions and varying degrees of visual impairment.
The Docket will open for public commenting on September 29, 2023. The Comments regarding the workshop should be submitted to the docket FDA-2023-N-3787 by October 30, 2023. Please refer to the Instructions for Submitting Comments available in the Docket to ensure that your feedback is received. The resulting discussions from the workshop and comments received in the docket will be taken into consideration.
Questions?
For more information or questions about the workshop, including the agenda, please visit the National Institutes of Health’s National Eye Institute virtual public workshop page.
